Iovance Biotherapeutics
IOVA
$13.45
Share price
0.45%
Change (1 day)
82.74%
Change (1 year)
Categories
Earnings for Iovance Biotherapeutics (IOVA)
Earnings in 2023 (TTM): -$0.47 B
According to Iovance Biotherapeutics 's latest financial reports the company's current earnings (TTM) are -$0.47 B. a decrease over its 2022 earnings that were of -$0.4 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Iovance Biotherapeutics from 2008 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.47 B | 15.46% |
| 2022 | -$0.4 B | 16.39% |
| 2021 | -$0.35 B | 30.83% |
| 2020 | -$0.27 B | 26.62% |
| 2019 | -$0.21 B | 61.29% |
| 2018 | -$0.13 B | 38.09% |
| 2017 | -$92.88 M | 73.16% |
| 2016 | -$53.64 M | 92.7% |
| 2015 | -$27.84 M | 131.17% |
| 2014 | -$12.05 M | -51.71% |
| 2013 | -$24.94 M | 6291.81% |
| 2012 | -$0.4 M | |
| 2008 | -$0.06 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.17 M | -99.53% | Bahamas |
 NRC Health
NRC | $40.82 M | -108.86% | 🇺🇸 USA |